These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24987558)

  • 1. Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population.
    Ban JY; Yoo KH
    Int Neurourol J; 2014 Jun; 18(2):63-7. PubMed ID: 24987558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 10-1-6 gene cluster polymorphisms are not associated with benign prostatic hyperplasia in korean population.
    Kim SK; Kim YO; Lee BC; Yoo KH; Chung JH
    Int Neurourol J; 2014 Mar; 18(1):10-5. PubMed ID: 24729922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
    Yoo KH; Kim SK; Chung JH; Chang SG
    Asian J Androl; 2010 Sep; 12(5):690-6. PubMed ID: 20562898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia.
    Kim SK; Chung JH; Park HC; Kim JH; Ann JH; Park HK; Lee SH; Yoo KH; Lee BC; Kim YO
    Exp Ther Med; 2015 Nov; 10(5):1990-1994. PubMed ID: 26640585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects.
    Mhatre DR; Mahale SD; Khatkhatay MI; Achrekar SK; Desai SS; Jagtap DD; Dhabalia JV; Tongaonkar HB; Dandekar SP; Varadkar AM
    Springerplus; 2015; 4():380. PubMed ID: 26240778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of influence of MSMB promoter rs10993994 polymorphisms on prostate cancer risk.
    Fu S; Huang YL; Luan T; Li N; Wang HF; Wang JS
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9295-9303. PubMed ID: 31773691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.
    Kim SK; Park HK; Choi HS; Yoo KH; Chung JH
    Int Neurourol J; 2016 Dec; 20(4):363-370. PubMed ID: 28043105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of LTβR gene polymorphisms with prostate volume in benign prostatic hyperplasia in the Korean population.
    Lee SH; Kim SK; Yoo KH; Chung JH; Chang SG
    Genet Mol Res; 2015 Dec; 14(4):18607-15. PubMed ID: 26782510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
    Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
    Xu X; Valtonen-André C; Sävblom C; Halldén C; Lilja H; Klein RJ
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2035-42. PubMed ID: 20696662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
    Whitaker HC; Kote-Jarai Z; Ross-Adams H; Warren AY; Burge J; George A; Bancroft E; Jhavar S; Leongamornlert D; Tymrakiewicz M; Saunders E; Page E; Mitra A; Mitchell G; Lindeman GJ; Evans DG; Blanco I; Mercer C; Rubinstein WS; Clowes V; Douglas F; Hodgson S; Walker L; Donaldson A; Izatt L; Dorkins H; Male A; Tucker K; Stapleton A; Lam J; Kirk J; Lilja H; Easton D; ; ; ; Cooper C; Eeles R; Neal DE
    PLoS One; 2010 Oct; 5(10):e13363. PubMed ID: 20967219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of prostate cancer susceptibility variant (MSMB) rs10993994 with risk of spermatogenic failure.
    Wu W; Lu J; Yuan B; Qin Y; Chen M; Niu X; Xu B; Lu C; Xia Y; Chen D; Sha J; Wang X
    Gene; 2013 Jul; 524(2):197-202. PubMed ID: 23608167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.
    Peng T; Zhang L; Zhu L; Mi YY
    Oncotarget; 2017 Apr; 8(17):28494-28501. PubMed ID: 28212531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
    Sjöblom L; Saramäki O; Annala M; Leinonen K; Nättinen J; Tolonen T; Wahlfors T; Nykter M; Bova GS; Schleutker J; Tammela TL; Lilja H; Visakorpi T
    PLoS One; 2016; 11(3):e0150241. PubMed ID: 26939004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the promoter regions of the CXCL1 and CXCL2 genes contribute to increased risk of alopecia areata in the Korean population.
    Kim SK; Chung JH; Park HJ; Kang SW; Lim DJ; Byun SH; Baek DG; Ko HY; Lew BL; Baik HH; Sim WY
    Genet Mol Res; 2015 Aug; 14(3):9667-74. PubMed ID: 26345899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population.
    Seok H; Kim SK; Yoo KH; Lee BC; Kim YO; Chung JH
    J Exerc Rehabil; 2014 Dec; 10(6):383-8. PubMed ID: 25610824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
    Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
    Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
    Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
    Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.
    Yoo KH; Kim SK; Chung JH; Chang SG
    J Korean Med Sci; 2011 May; 26(5):659-64. PubMed ID: 21532858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.